Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) subsidiary's freeze-dried rabies vaccine for human use has obtained a sales license in Macau.

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that recently, Guangzhou Baiyunshan Pharmaceutical Holdings Biological Products Co., Ltd. (referred to as "Guangzhou Baiyunshan Pharmaceutical Holdings Biological") within the scope of its consolidated financial statements received the Freeze-dried Human Rabies Vaccine (Vero Cells) "Drug Registration Certificate" issued by the Macao Special Administrative Region Government's Drug Safety Administration. Reportedly, this drug is used to prevent rabies. The drug will be sold in the Macao region by Guangzhou Baiyunshan Pharmaceutical Holdings Biological through its authorized distributor, Guangzhou Pharmaceutical International (Macao) Pharmaceutical Products Import and Export and Wholesale Limited, which will help Guangzhou Baiyunshan Pharmaceutical Holdings Biological expand its overseas market business and enhance the market competitiveness of the company's products. To date, Guangzhou Baiyunshan Pharmaceutical Holdings Biological has invested approximately 205 million yuan (unaudited) in the research and development of the freeze-dried human rabies vaccine (Vero Cells) project.